Cumberland Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-170,790	Closed	-$13.5M	–	60
2022 Q3	$13.5M	Sell	170,790 -6,735	-4%	-$568K	5.39%	6
2022 Q2	$13.2M	Sell	177,525 -138,790	-44%	-$10.4M	4.38%	6
2022 Q1	$28.4M	Buy	316,315 +63,101	+25%	+$5.83M	6.59%	3
2021 Q4	$28.4M	Sell	253,214 -4,100	-2%	-$495K	5.94%	3
2021 Q3	$32.3M	Buy	257,314 +20,055	+8%	+$2.58M	7.48%	2
2021 Q2	$32.1M	Buy	237,259 +66,018	+39%	+$8.68M	7.54%	2
2021 Q1	$23.2M	Buy	171,241 +3,216	+2%	+$482K	5.76%	3
2020 Q4	$23.7M	Buy	+168,025	New	+$21.5M	8.66%	2
2020 Q2	$13.5M	Sell	120,269 -87,240	-42%	-$8.59M	5.1%	6
2020 Q1	$16.1M	Sell	207,509 -645	-0.3%	-$57.1K	6.55%	4
2019 Q4	$19.8M	Sell	208,154 -2,905	-1%	-$251K	6.82%	4
2019 Q3	$16.1M	Buy	211,059 +5,230	+3%	+$435K	4.55%	6
2019 Q2	$18.1M	Sell	205,829 -3,250	-2%	-$277K	6.09%	5
2019 Q1	$18.9M	Buy	209,079 +23,660	+13%	+$2.01M	6.56%	5
2018 Q4	$13.3M	Buy	185,419 +128,779	+227%	+$10.4M	4.77%	7
2018 Q3	$5.43M	Buy	56,640 +13,420	+31%	+$1.3M	3.63%	11
2018 Q2	$4.11M	Buy	43,220 +1,270	+3%	+$117K	2.57%	18
2018 Q1	$3.68M	Buy	41,950 +290	+0.7%	+$26.5K	2.25%	21
2017 Q4	$3.54M	Buy	41,660 +37,560	+916%	+$3.15M	1.95%	23
2017 Q3	$355K	Sell	4,100 -60	-1%	-$4.81K	0.22%	40
2017 Q2	$321K	Hold	4,160	–	–	0.19%	42
2017 Q1	$288K	Sell	4,160 -1,300	-24%	-$87.3K	0.18%	36
2016 Q4	$323K	Buy	+5,460	New	+$337K	0.23%	35
2016 Q2	–	Sell	-38,160	Closed	-$1.97M	–	57
2016 Q1	$1.97M	Buy	+38,160	New	+$1.98M	1.36%	20
2013 Q4	–	Sell	-77,970	Closed	-$3.36M	–	40
2013 Q3	$3.36M	Buy	77,970 +18,090	+30%	+$733K	1.99%	15
2013 Q2	$2.08M	Buy	+59,880	New	+$2.1M	1.14%	32